These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 773025)

  • 1. [The clinical experience with the decarboxylase-blocked levodopa (Nacom) in the Parkinsonism patients].
    Völler GW; Deze J
    ZFA (Stuttgart); 1976 Mar; 52(7):380-8. PubMed ID: 773025
    [No Abstract]   [Full Text] [Related]  

  • 2. Amantadine and a fixed combination of carbidopa and levodopa in parkinsonism: a preliminary report.
    Savery F
    Curr Ther Res Clin Exp; 1976 Mar; 19(3):337-8. PubMed ID: 817863
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of Parkinson's disease with levodopa and a dopa decarboxylase inhibitor].
    Londoõ R
    Neurol Neurocir Psiquiatr; 1976; 17(4):293-300. PubMed ID: 1018729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sinemet.
    Drug Ther Bull; 1974 Oct; 12(21):83-4. PubMed ID: 4617660
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of Parkinson's syndrome with a combination of levodopa and carbidopa].
    Lombardo L; De la Garza R
    Arch Invest Med (Mex); 1977; 8(2):123-8. PubMed ID: 907417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of Parkinson's syndrome with L-dopa and L-carbidopa (author's transl)].
    Hanzal F
    MMW Munch Med Wochenschr; 1976 May; 118(20):653-6. PubMed ID: 818540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Carbiodopa-levodopa therapy (Sinemet) in the treatment of parkinsonian patients. Results of 4 years of treatment].
    Martínez-Lage JM; Burguera JA; Deldago G; Zubieta JL
    Arch Neurobiol (Madr); 1978; 41(1):3-18. PubMed ID: 697513
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of dopa decarboxylase inhibitor (carbidopa) combined with levodopa and levodopa alone in Parkinson's disease.
    Lieberman A; Goodgold A; Jonas S; Leibowitz M
    Neurology; 1975 Oct; 25(10):911-6. PubMed ID: 1101099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Carbidopa-levodopa, growth hormone and parkinsonism].
    Marti-Masso JF; Carrera N; Martínez-Lage JM
    Rev Clin Esp; 1976 Jun; 141(6):525-32. PubMed ID: 968087
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug therapy for Parkinsonism.
    Walker E
    Mod Healthc (Short Term Care); 1976 Jan; 5(1):62. PubMed ID: 1652
    [No Abstract]   [Full Text] [Related]  

  • 11. L-dopa and carbidopa (sinemet) in the management of parkinsonism.
    Critchley E
    Postgrad Med J; 1975 Sep; 51(599):619-21. PubMed ID: 1105500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levodopa with benserazide or carbidopa in Parkinson disease.
    Rinne UK; Mölsä P
    Neurology; 1979 Dec; 29(12):1584-9. PubMed ID: 574221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of combining carbidopa with levodopa for Parkinson's disease.
    Martin WE; Tolosa ES; Loewenson RB; Lee MC; Resch JA; Baker AB
    Geriatrics; 1975 Dec; 30(12):39-44. PubMed ID: 1104406
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of Parkinson's syndromes by a combination of levodopa with decarboxylase inhibitors].
    Hanzal F
    Cesk Neurol Neurochir; 1975 Dec; 38(6):327-32. PubMed ID: 1192544
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparative clinical investigation of the therapeutic effect of levodopa alone and in combination with a decarboxylase inhibitor (carbidopa) in cases of Parkinson's disease.
    Wajsbort J; Dorner A; Wajsbort E
    Curr Med Res Opin; 1978; 5(9):695-708. PubMed ID: 367714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromocriptine in the treatment of Parkinson's disease: a double-blind study against L-dopa/carbidopa.
    Gawel M; Riopelle R; Libman I; Bouchard S
    Adv Neurol; 1987; 45():535-8. PubMed ID: 3548263
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of Parkinson's disease with the combination drug L-carbidopa/L-dopa. Report on a 2 years study].
    Hayek J
    Schweiz Med Wochenschr; 1977 Apr; 107(14):474-9. PubMed ID: 847450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Madopar versus sinemet. A clinical study on their effectiveness.
    Korten JJ; Keyser A; Joosten EM; Gabreëls FJ
    Eur Neurol; 1975; 13(2):65-71. PubMed ID: 1095374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical picture and plasma levodopa metabolite profile of parkinsonian nonresponders. Treatment with levodopa and decarboxylase inhibitor.
    Rivera-Calimlim L; Tandon D; Anderson F; Joynt R
    Arch Neurol; 1977 Apr; 34(4):228-32. PubMed ID: 843257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of "on-off effect" with a dopa decarboxylase inhibitor.
    Sweet RD; McDowell FH; Wasterlain CG; Stern PH
    Arch Neurol; 1975 Aug; 32(8):560-3. PubMed ID: 1156214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.